Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.

NCT00367211 is registered in ClinicalTrials.gov with POZEN as lead sponsor.

NCT NCT00367211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00367211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.
Lead sponsor
POZEN
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2006
Completion date
September 30, 2007
Enrollment
400
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, osteoarthritis, rheumatoid arthritis